July 28, 2026

Xylazine Detection in Urine Drug Tests: Insights Into Illicit Drug Trends

National urine drug testing data showed increasing xylazine detection despite declining urinary concentrations in fentanyl-positive samples, suggesting complementary measures of changes in the illicit drug supply.

Conexiant

July 28, 2026

Germline Variants May Signal Early Breast Cancer Relapse

Patients carrying moderate- to high-risk breast cancer variants had poorer breast cancer–free survival, whereas polygenic risk scores did not improve prognostic stratification.

Conexiant

July 27, 2026

Colorectal Cancer Screening Blood Test Approved by FDA

The blood-based assay demonstrated 81% sensitivity for colorectal cancer in the PREEMPT CRC study.

Conexiant

July 20, 2026

Can Endotoxin-Targeted Care Improve Sepsis Outcomes?

Biomarker-guided patient selection may help identify patients with sepsis who could benefit from endotoxin-targeted therapy, although confirmatory evidence is still needed.

Conexiant

July 14, 2026

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.

Conexiant

July 14, 2026

Autism Spectrum Disorder Linked to Distinct Urine Metabolite Pattern

Researchers proposed a new autism spectrum disorder phenotype characterized by elevated urinary microbially derived metabolites.

Conexiant

July 08, 2026

Self-Sampling Shows Test Agreement

The study authors frame the device as a potential way to simplify screening, while emphasizing that larger validation studies are still needed.

Conexiant

July 02, 2026

FDA Expands Gene Therapy for Younger Patients

Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

Conexiant

July 02, 2026

Does Structured Reporting Improve Lung Cancer Reports?

A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.

Conexiant

July 01, 2026

FDA Approves Treg Cell Therapy

A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers.

Conexiant